EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers

Mark J Mitton-Fry iD, Jason E Cummings, Yanran Lu, Jillian F Armenia, Jo Ann W Byl, Alexandria A Oviatt iD, Allison A Bauman, Gregory T Robertson, Neil Osheroff iD, Richard A Slayden

ACS Infectious Diseases · 2025

DOI: 10.1021/acsinfecdis.4c00743 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2025. Verfasst von Mark J Mitton-Fry und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Antitubercular Agents, Topoisomerase II Inhibitors, Topoisomerase Inhibitors. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisAntitubercular AgentsTopoisomerase II InhibitorsTopoisomerase InhibitorsAnimalsHumansMiceMicrobial Sensitivity TestsDNA GyraseTuberculosisMacrophagesDrug Resistance, BacterialFemaleDisease Models, Animal

Stichwörter der Autor:innen

drug discoverygyrasenovel bacterial topoisomerase inhibitorsresistancetuberculosis

Substanzen

Antitubercular AgentsDNA GyraseTopoisomerase II InhibitorsTopoisomerase Inhibitors

Autor:innen und Institutionen

  • Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, Ohio 43210, United States.
  • Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado 80523, United States.
  • Department of Biochemistry, Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.
  • Department of Medicine (Hematology/Oncology), Vanderbilt University School of Medicine, Nashville, Tennessee 37232, United States.

ORCID-Profile: Mark J Mitton-Fry, Alexandria A Oviatt, Neil Osheroff

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • NIGMS NIH HHS
  • NICHD NIH HHS
  • CLC NIH HHS
  • Dr. Ralph and Marian Falk Medical Research Trust
  • National Institute of Allergy and Infectious Diseases
  • Cystic Fibrosis Foundation

Zitieren

APA

Mitton-Fry, M. J., Cummings, J. E., Lu, Y., Armenia, J. F., Byl, J. A. W., Oviatt, A. A., Bauman, A. A., Robertson, G. T., Osheroff, N., & Slayden, R. A. (2025). Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.4c00743

Vancouver

Mitton-Fry MJ, Cummings JE, Lu Y, Armenia JF, Byl JAW, Oviatt AA, et al. Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers. ACS Infectious Diseases. 2025. doi:10.1021/acsinfecdis.4c00743

BibTeX
@article{MittonFry2025,
  author = {Mitton-Fry, Mark J and Cummings, Jason E and Lu, Yanran and Armenia, Jillian F and Byl, Jo Ann W and Oviatt, Alexandria A and Bauman, Allison A and Robertson, Gregory T and Osheroff, Neil and Slayden, Richard A},
  title = {Anti-Mycobacterial Activity of Bacterial Topoisomerase Inhibitors with Dioxygenated Linkers},
  journal = {ACS Infectious Diseases},
  year = {2025},
  doi = {10.1021/acsinfecdis.4c00743}
}
Kostenlos starten →